Genedrive (GDR)

Sector:

Health Care

Index:

FTSE AIM All-Share

5.00p
   
  • Change Today:
    -0.38p
  • 52 Week High: 22.25
  • 52 Week Low: 3.13
  • Currency: UK Pounds
  • Shares Issued: 143.14m
  • Volume: 506,281
  • Market Cap: £7.16m
  • RiskGrade: 747

ShareCast News

Genedrive makes progress with Covid-19 test deve... 01-Jul-2021 ShareCast
Genedrive Covid-19 test formally approved in India 30-Apr-2021 ShareCast
Genedrive appointed to PHE microbiology supply f... 19-Apr-2021 ShareCast
Genedrive notifies FDA of intent to distribute C... 16-Dec-2020 ShareCast
Genedrive gets approval for Covid-19 kit in Sout... 30-Sep-2020 ShareCast
Genedrive revenues tumble as Covid-19 hits pre-e... 10-Jul-2020 ShareCast
Genedrive gets CE-mark for Covid-19 test kit 22-May-2020 ShareCast
Genedrives completes manufacturing milestone for... 01-May-2020 ShareCast
Genedrive upbeat on latest results from RNR1 kit... 03-Dec-2019 ShareCast
Genedrive infant hearing loss test gets CE mark 18-Nov-2019 ShareCast
Genedrive loss narrowed after double-digit reven... 03-Oct-2019 ShareCast
Genedrive losses narrow despite increased R&D co... 28-Mar-2019 ShareCast
Genedrive makes progress with HCV kit in first h... 15-Jan-2019 ShareCast
Genedrive to participate in three-country HCV th... 29-Nov-2018 ShareCast
Genedrive losses widen, announces £6m placing 16-Nov-2018 ShareCast
Genedrive revenues slip following completion of ... 13-Jul-2018 ShareCast
Genedrive and partners awarded grant for develop... 20-Jun-2018 ShareCast
Genedrive appoints former Alere Africa head to t... 09-Apr-2018 ShareCast
Genedrive presents hepatitis C assay in Singapore 03-Apr-2018 ShareCast
Genedrive awarded 'significant funding' for tube... 27-Feb-2018 ShareCast
Genedrive awarded £484,000 grant by Innovate UK 21-Nov-2017 ShareCast
Gendedrive inks second distribution agreement wi... 14-Nov-2017 ShareCast
Genedrive COO Allan Brown to leave 08-Nov-2017 ShareCast
Genedrive to launch decentralised Hepatitis C as... 02-Nov-2017 ShareCast
Genedrive to launch decentralised Hepatitis C as... 23-Oct-2017 ShareCast
Genedrive signs distribution agreement with Sysmex 16-Oct-2017 ShareCast
Genedrive attains CE marking for Hepatitis C ide... 11-Sep-2017 ShareCast
Genedrive announces additional US defence funding 27-Jul-2017 ShareCast
Genedrive posts solid revenue growth 13-Jul-2017 ShareCast
Genedrive's revenues rise despite difficulties i... 27-Jan-2017 ShareCast
Genedrive supplies field test units to US DoD 16-Jan-2017 ShareCast
Genedrive's revenue rises while it re-focuses co... 11-Oct-2016 ShareCast
Genedrive appoints Matthew Fowler CFO 21-Sep-2016 ShareCast
US DoD awards another £2m for Epistem biohazard ... 21-Mar-2016 ShareCast
Hangar 8 CEO makes first sale to meet demand for... 03-Dec-2013 ShareCast
EpiStem loses distribution contract for TB test 09-Sep-2013 ShareCast
Epistem to raise 4.3m pounds via placing 07-Dec-2012 ShareCast
Investec invests in Epistem 24-Oct-2012 ShareCast
Epistem delivers steady performance 16-Oct-2012 ShareCast
Epistem secures contract for TB test 06-Aug-2012 ShareCast
Small caps round-up: Epistem, Stadium Group, Tra... 05-Jul-2012 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genedrive Market Data

Currency UK Pounds
Share Price 5.00p
Change Today -0.38p
% Change -6.98 %
52 Week High 22.25
52 Week Low 3.13
Volume 506,281
Shares Issued 143.14m
Market Cap £7.16m
RiskGrade 747

Genedrive Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
40.55% below the market average40.55% below the market average40.55% below the market average40.55% below the market average40.55% below the market average
29.03% below the sector average29.03% below the sector average29.03% below the sector average29.03% below the sector average29.03% below the sector average
Price Trend
91.03% below the market average91.03% below the market average91.03% below the market average91.03% below the market average91.03% below the market average
72.97% below the sector average72.97% below the sector average72.97% below the sector average72.97% below the sector average72.97% below the sector average
Income Not Available
Growth
44.6% below the market average44.6% below the market average44.6% below the market average44.6% below the market average44.6% below the market average
66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average

Genedrive Dividends

No dividends found

Trades for 29-Apr-2024

Time Volume / Share Price
16:19 38 @ 5.25p
15:45 1,557 @ 5.02p
15:12 25,000 @ 5.17p
15:12 146 @ 5.00p
15:12 7 @ 5.00p

Genedrive Key Personnel

CFO Russell Shaw
CEO James Cheek

Top of Page